Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 03, 2022
Share
Raia Drogasil S.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was BRL 6,562.51 million compared to BRL 5,620.05 million a year ago. Net income was BRL 140.64 million compared to BRL 174.3 million a year ago. Basic earnings per share from continuing operations was BRL 0.08537 compared to BRL 0.10565 a year ago. Diluted earnings per share from continuing operations was BRL 0.08445 compared to BRL 0.10481 a year ago.
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.